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The new, potentially ambidentate heterocyclic ligand 2,3-bis(1-methylimidazol-2-yl)quinoxaline (bmiq)
was obtained from 2,3-bis(1-methylimidazol-2-yl)glyoxal and 1,2-diaminobenzene. Its coordination to
PtCl2 and to the isoelectronic [AuCl2]+ in [AuCl2(bmiq)](AuCl4) occurs via the imine N donors of the
imidazolyl groups, leading to the formation of seven-membered chelate rings with boat conformation.
According to the spectroelectrochemistry (UV-vis-NIR, EPR), the reversible electron addition to the
[PtCl2(bmiq)] and the free ligand takes place in the (non-coordinated) quinoxaline part of the molecule,
similarly as for related complexes of dipyrido[3,2-a:2¢,3¢-c]phenazines (dppz), 2,3-bis(2-pyridyl)-
quinoxalines (bpq) and 2,3-bis(dialkylphosphino)quinoxalines (QuinoxP). DFT calculations conﬁrm
the experimental results (structures, spectroscopy) and also point to the coordination potential of the
quinoxaline N atoms. The electron addition to [AuCl2(bmiq)]+ takes place not at the ligand but at the
metal site, according to experimental and DFT results.
Introduction
The coordination compounds of ligands in which the metal
binding location and the electron transfer site are spatially and
electronically separated have raised attention in various areas. The
molecule dipyrido[3,2-a:2¢,3¢-c]phenazine (dppz, Scheme 1) and its
many derivatives were thus shown by various techniques to exhibit
such a situation1 and the ability of certain complexes of dppz to
exhibit environmentally and, especially, intercalation dependent
luminescence made them popular as “molecular light switches”.2
Speciﬁcally, the chelate coordination to form a ﬁve-membered ring
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Scheme 1
occurs at the a-diimine site of the 1,10-phenanthroline part of the
molecule, whereas the rather facile electron addition takes place
mainly in the quinoxaline moiety.1a
The 2,3-bis(dialkylphosphino)quinoxaline ligands (QuinoxP,
Scheme 1), although developed for the purpose of stereoselective
organic catalysis with an oxidatively stable diphosphine,3 were
shown to exhibit a similar separation of chelate coordination
activity (at the diphosphine site) and electron transfer (at the
quinoxaline heterocycle).4
A related type of ligand is based on the commercially available
2,3-bis(2-pyridyl)quinoxaline (dpq).5
We have now obtained another such system, 2,3-bis(1-
methylimidazol-2-yl)quinoxaline (bmiq, Scheme 2), by reacting
1,2-diaminobenzene (o-phenylenediamine) with the known 2,3-
bis(1-methylimidazol-2-yl)glyoxal.6
In addition to using the biorelevant imidazole substituents,
reminiscent of the histidine side chain,7,8 we were interested in
probing the possibility of chelation via both imidazol-2-yl imine
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Scheme 2
N donors to form a seven-membered chelate ring (A, Scheme 3)
or via one imidazol-2-yl imine N and one quinoxaline N to
result in a perhaps stabilized ﬁve-membered chelate ring situation
(B, Scheme 3). Using the [PtCl2] complex fragment, which was
employed before for QuinoxP4 and dpq5b,c and the isoelectronic
[AuCl2]+ we report here the synthesis, and the structural, spectro-
scopic and spectroelectrochemical characterisation of the bmiq
ligand and its PtCl2 and [AuCl2]+ complexes, as well as DFT
calculations of these species and of their one-electron reduced
forms.
Scheme 3
Platinum(II) complexes have been studied widely because they
can exhibit a large range of special properties: some of themare be-
ing successfully applied as cytostatica in the therapy of tumours,9
they frequently emit in the solution and in the solid state,10
their physical properties can be very sensitive towards the en-
vironment (solvatochromism, thermochromism, vapochromism,
ionochromism),11 they may be used as precursor or supporting
materials in the conversion of solar energy,12 they can aggregate
via s/s or p/p interactions (e.g. stacking), their crystallisation
variants often exhibit different physical characteristics,13 they
can be electrochemically active if coordinated to a non-innocent
ligand,14 the inert bonds can be employed for studies of reaction
mechanisms,15 they can be converted to efﬁciently C–H activating
catalysts16 and they may serve as structure maintaining vertices
of large supramolecular frameworks.17 Although isoelectronic
to PtCl2, the [AuCl2]+ analogue is clearly more reducible, i.e.
distinguished by lower lying unoccupied MOs. This study will
illustrate the differences between the corresponding complexes
with the new bmiq p acceptor ligand.
Experimental
Instrumentation
EPR spectra in the X band (9.5 GHz) were recorded with a Bruker
System EMX. UV-vis-NIR absorption spectra were recorded
on J&M TIDAS and Shimadzu UV 3101 PC spectrophotometers.
Fluorescence of the samples in solution, as well as in the solid
phase, was studied using a Perkin–Elmer LS50B spectrophotome-
ter at room temperature, within the range of 200–800 nm. Cyclic
voltammetry was carried out in 0.1 M Bu4NPF6 solutions using a
three-electrode conﬁguration (glassy carbon working electrode, Pt
counter electrode,Ag/AgCl reference) and aPAR273potentiostat
and function generator. The ferrocene/ferrocenium (Fc/Fc+)
couple served as internal reference. Spectroelectrochemistry was
performed using an optically transparent thin-layer electrode
(OTTLE) cell.18a A two-electrode capillary served to generate
intermediates for the X band EPR studies.18b
Syntheses
2,3-Bis(1-methylimidazol-2-yl)quinoxaline (bmiq). The prepa-
ration of the ligand was performed using a similar procedure
to that of the dipyrrole analogue.19 A mixture of 30 mg (0.137
mmol) of 2,3-bis(1-methylimidazol-2-yl)glyoxal and 39.69 mg
(0.367 mmol) of o-phenylenediamine was dissolved in 8 mL of
glacial acetic acid and stirred at 90 ◦C for 12 h in the dark
under an argon atmosphere. After the removal of the solvent
the viscous substance was chromatographed on a silica column
where 30.6 mg (77% yield) of pure product could be obtained with
ethanol–ethyl acetate (1 : 1). Single crystals for X-ray diffraction
were obtained from methylene chloride/hexane. Anal. calcd for
C16H14N6 (290.33): C 66.19, H 4.86, N 28.95. Found: C 65.39,
H 4.56, N 28.29%. MS (%): 313.12 (100, M+ +Na), 291.13
(55, M++H). 1H NMR (DMSO-d6): 3.74 (6H, s, CH3), 6.84
(2H, br s, imidazole), 7.26 (2H, br s, imidazole), 7.95 (2H, m,
quinoxaline), 8.17 (2H, m, quinoxaline). 1H NMR (CD3CN): 3.81
(6H, s, CH3), 6.89 (2H, s, imidazole), 7.12 (2H, s, imidazole),
7.93 (2H, m, quinoxaline), 8.14 (2H, m, quinoxaline). 13C NMR
(DMSO-d6): 33.97, 123.6, 127.4, 129.12, 132.2, 139.78, 143.86,
145.64. UV-vis (CH3CN), lmax (nm) [e (mol dm-3 cm-1)]: 367
[10 300], 289 [14 800], 247 [28 250].
[PtCl2(bmiq)]. To 50.5 mg of bmiq (0.173 mmol) in 15 mL of
acetonitrile was added 0.73 mg of [PtCl2(dmso)2] (0.173 mmol) in
15mLCH3CN.After stirring for 12 h at 60 ◦C, the pale yellow solid
formed was ﬁltered to give 50 mg (51.9%) of product, which gave
single-crystal X-ray suitable crystals from nitromethane. Anal.
calcd forC16H14Cl2N6Pt (556.32): C 34.54,H2.54,N15.11. Found:
C 34.38, H 2.30, N 14.44%. 1HNMR (CD3CN): 3.86 (6H, s, CH3),
7.33 (4H, br s, imidazole), 8.06 (2H, m, quinoxaline), 8.30 (2H, m,
quinoxaline). 195Pt satellite lines could not be observed because of
the poor solubility of the complex. This also prevented us from
determining exact molar extinction values. UV-vis (CH3CN), lmax
(nm): 362, 273, 246.
[AuCl2(bmiq)][AuCl4]. To 38.7 mg of KAuCl4 (0.1 mmol) in
15 mL of methanol was added 28 mg of bmiq (0.1 mmol) in 15 mL
CH3OH. After stirring for 4 h in the dark, the yellow solid that
formed was ﬁltered to give 51 mg (58%) of product. Single-crystal
X-ray suitable crystalswere obtained fromacetonitrile.Anal. calcd
for C16H14Au2Cl6N6 (896.97): C 21.43, H 1.57, N 9.37. Found: C
22.84, H 1.42, N 9.60%. 1H NMR (CD3CN): 3.96 (6H, s, CH3),
7.51 (2H, br s, imidazole), 7.65 (2H, br s, imidazole), 8.19 (2H,
m, quinoxaline), 8.35 (2H, m, quinoxaline). UV-vVis (CH3CN),
lmax (nm) [e (mol dm-3 cm-1)]: 360 sh, 337 [8570], 276 [23 070], 250
[26 900].
Crystallography. Single crystals of bmiq, [PtCl2(bmiq)] and
[AuCl2(bmiq)](AuCl4) were obtained by slow evaporation from
saturated solutions (see above). Data were collected for se-
lected specimens: bmiq, colourless lath (3.3 ¥ 1.1 ¥ 1.0 mm);
















































Table 1 Crystallographic data
bmiq [PtCl2(bmiq)] [AuCl2(bmiq)](AuCl4)
empirical formula C16H14N6 C16H14Cl2N6Pt C16H14Au2Cl6N6
FW 290.33 556.32 896.97
Space group P21/n P21/c P21/n
a/A˚ 9.0875(5) 14.5272(7) 9.7732(2)
b/A˚ 10.3843(7) 9.5752(4) 24.6103(5)
c/A˚ 14.7640(8) 13.5829(7) 10.1615(2)
b/◦ 105.664(3) 101.724(2) 107.0950(10)
V/A˚3 1341.50(14) 1849.98(12) 2336.08(8)
Z 4 4 4
Dc/g cm-3 1.438 1.997 2.550
m/mm-1 0.09 7.89 13.25
Rint 0.105 0.044 0.047
R1 0.090 0.060 0.047
wR2 0.163 0.110 0.071
GooF 1.079 1.057 1.021
largest difference
peak/hole/e A˚-3
0.382/- 0.343 3.143/- 3.196 1.840/- 1.926
[PtCl2(bmiq)], colourless platelet (0.7 ¥ 0.6 ¥ 0.2 mm) and
[AuCl2(bmiq)](AuCl4), reddish platelet (2.2 ¥ 1.2 ¥ 0.8 mm).
A NONIUS Kappa CCD diffractometer was used at 100 K,
additional crystallographic information is given in Table 1. The
structures were solved using direct methods with reﬁnement by
full-matrix least squares of F 2, employing the program system
SHELXL 9720 in connection with a numerical absorption correc-
tion in case of bmiq and an empirical correction for [PtCl2(bmiq)]
and [AuCl2(bmiq)](AuCl4). All non-hydrogen atoms were reﬁned
anisotropically.
DFT calculations
Density functional theory (DFT) calculations were carried out
using the program package GAUSSIAN.21 The hybrid functional
B3LYP (UB3LYP for radical anions) with the LANL2DZ basis
set was employed.6c The ligand, the complexes and their one-
electron reduced forms were subjected to calculations. Also, PtCl2
complexes yielding a 7-membered (A) and a 5-membered (B)
chelate ring were studied (see Scheme 3).
Results and discussion
Synthesis and structure
The new heterocycle bmiq has been obtained via a standard syn-
thetic condensation procedure for preparing quinoxalines,19 using
the previously introduced6 2,3-bis(1-methylimidazol-2-yl)glyoxal.
The compound was characterised by single-crystal X-ray crystal
diffraction (Table 1), the molecules in the crystal studied exhibit
a pronounced, unsymmetrical twisting between the planes of
the quinoxaline p-acceptor system and the p electron donating
methylimidazolyl substituents (Fig. 1, Table 2).
The complexation of bmiq with PtCl2 involving the
[PtCl2(dmso)2] precursor gave a single mononuclear product,
[PtCl2(bmiq)], characterised by 1H-NMR and single-crystal X-ray
crystallography as the symmetrically methylimidazolyl-chelated
coordination compound (Fig. 2). The resulting seven-membered
ring, involvingboth imine functions of the imidazoles, is not planar
but exhibits a typical6 boat conformation (Table 2). The dihedral
Fig. 1 The molecular structure of bmiq in the crystal (ellipsoid probabil-
ity: 95%).
Fig. 2 The molecular structure of [PtCl2(bmiq)] in the crystal (ellipsoid
probability: 95%).
angles between the quinoxaline and the imidazolyl rings amount
to about 69◦.
A similar chelation and conformation was found for
[AuCl2(bmiq)]+, which was obtained as the tetrachloroaurate salt
from the reaction of bmiq with KAuCl4 (Fig. 3, Table 2).
Signiﬁcant intermolecular interactions were not observed for
the compounds presented here, presumably due to the non-planar
molecular structures with severely twisted methylimidazolyl sub-
stituents. The structural properties of bmiq and its complexes
could be well reproduced by DFT calculations (Table 2). This
method suggested a higher energy for the ﬁve-membered chelate
alternative B (Scheme 3) over the experimentally observed seven-
membered chelate form A by 12.42 kcal mol-1 in the case of the
PtCl2 complex.
















































Table 2 Experimental and calculated bond lengths and angles for compounds















N1–C1 1.321(3) 1.348 1.358 1.349(8) 1.355 1.360 1.332(7) 1.359 1.392
N1–C3 1.377(3) 1.386 1.391 1.364(8) 1.387 1.392 1.374(7) 1.390 1.386
N2–C1 1.364(3) 1.389 1.398 1.346(8) 1.385 1.387 1.353(7) 1.374 1.388
N2–C2 1.373(3) 1.390 1.397 1.371(8) 1.391 1.396 1.374(7) 1.393 1.392
C5–C10 1.439(3) 1.457 1.413 1.432(9) 1.457 1.418 1.421(7) 1.450 1.458
C5–N6 1.324(3) 1.340 1.395 1.327(7) 1.341 1.379 1.322(7) 1.342 1.344
C10–N5 1.322(3) 1.339 1.370 1.322(8) 1.342 1.379 1.300(7) 1.342 1.344
M–Cl1 2.300(2) 2.405 2.429 2.268(1) 2.383 2.504
M–Cl2 2.308(2) 2.405 2.429 2.257(1) 2.383 2.504
M–N1 2.005(5) 2.029 2.030 2.015(4) 2.058 2.228
M–N3 1.991(5) 2.029 2.030 2.014(4) 2.058 2.228
Bond angles/◦
N3–M–Cl1 89.5(2) 88.57 89.16 90.8(1) 89.96 88.82
N3–M–Cl2 177.3(2) 177.98 177.27 178.2(1) 178.63 172.36
N1–M–N3 88.4(2) 90.12 89.61 88.5(2) 89.50 85.43
N1–M–Cl2 89.9(2) 88.57 89.16 90.2(1) 89.96 89.96




48.91 61.31 76.21 69.03 66.97 64.80 71.15 64.97 61.53
Fig. 3 The molecular structure of [AuCl2(bmiq)]+ in the crystal of
[AuCl2(bmiq)][AuCl4] (ellipsoid probability: 95%).
Although PtCl2 compounds in particular can be light emitting
on excitation,10 the complex of bmiq was found to be non-
luminescent in the solid or in CH2Cl2 solution, probably due
to non-radiative decay involving the non-rigid methylimidazolyl
functions. The compound [AuCl2(bmiq)](AuCl4) showed emission
at 440 nm after excitation at 300 nm in dichloromethane.
One-electron reduction
The one-electron character of the primary reduction processes
in the free ligand bmiq and in the complexes was checked
coulometrically and, in the case of reversible steps, was conﬁrmed
by the nearly 60 mV difference between the cathodic peak and
Table 3 Electrochemical data of compounds
compound solventa T/K redox potentialb (V vs. Fc+/0)
bmiq CH2Cl2 293 -2.31 [70]c
[PtCl2(bmiq)] CH2Cl2 293 -1.62 [80]c
[AuCl2(bmiq)][AuCl4] C3H7CN 203 d
a 0.1 mol dm-3 Bu4NPF6 as electrolyte. b Half-wave potentials measured
at 100 mV s-1 scan rate; [peak potential differences/mV] c ipc/ipa ª 1.0.
d Irreversible reduction, interfering waves around 0.0 V from the two AuIII
species.
Fig. 4 The cyclic voltammogram of [PtCl2(bmiq)] in
CH2Cl2/0.1 mol dm-3 Bu4NPF6 (100 mV s-1 scan rate).
the anodic counter-peak in cyclic voltammetry (Fig. 4). Whereas
bmiq and its PtCl2 complex could be reduced reversibly to
the persistent radical anions bmiq∑- and [PtCl2(bmiq)]∑- under
ambient conditions, the gold(III) species [AuCl2(bmiq)](AuCl4)
showed only irreversible electron uptake, even at -70 ◦C in n-
butyronitrile. The inability to detect an in situ EPR signal leaves
the formation of a persistent species [AuCl2(bmiq)]∑ in question.
The complexes are more easily reduced than the free ligand
(Table 3), in agreement with the changed structure and with the
















































Fig. 5 ESR spectrum of bmiq∑- obtained by reduction of bmiq with K in
THF at 293 K.
Fig. 6 ESR spectrum of electrochemically generated [PtCl2(bmiq)]∑- at
293 K in CH2Cl2/0.1 mol dm-3 Bu4NPF6.
s-acceptor functions of the dichlorometal fragments. Both bmiq∑-
and [PtCl2(bmiq)]∑- show hyperﬁne-split EPR signals (Fig. 5 and
6), the spectra being dominated by 1 : 2 : 3 : 2 : 1 quintet coupling
from two equivalent 14N atoms, of 6.2 G and 6.0 G for bmiq∑- and
[PtCl2(bmiq)]∑-, respectively (195Pt coupling estimated at £ 10 G).
These values indicate22 spin concentration in the pyrazine ring
of the quinoxaline part of the molecule, an assumption which
is supported by DFT spin density calculations (Fig. 7 and 8)
and also by the structural changes calculated for the radical
anions bmiq∑- and [PtCl2(bmiq)]∑- (Table 2). The major changes
on reduction occur in the pyrazine ring, while the coordination
is mainly affected by the added charge. It is concluded, therefore,
that the electronic structure of bmiq and its complexes is similar to
that of the corresponding dppz, bpq and Quinox-P ligands, i.e. the
electron transfer site (quinoxaline) is spatially and electronically
separated from themetal binding site1a,4 (here: the imidazole rings).
Fig. 7 DFT calculated spin densities for bmiq∑-.
Although some additional hyperﬁne splitting is visible in the
EPR spectra (Fig. 5 and 6), the total number of theoretical lines
Fig. 8 DFT calculated spin densities for [PtCl2(bmiq)]∑-.
(70 875) from8different nuclei (5¥ 1H, 3¥ 14N) in bmiq∑- prevented
us from further analysis and assignment of the smaller (£1G) EPR
coupling constants.
The isotropic g values of bmiq∑- and [PtCl2(bmiq)]∑- differ
only slightly (2.0034 and 2.0004), which conﬁrms the hypothesis
on the separation of spin localisation and metal binding. The
dichloroplatinum(II) complexes of normal a-diimines (where elec-
tron accommodation and coordination are not separated) show a
much more pronounced shift of the isotropic g and a considerable
g anisotropy.23
The inability to detect a neutral paramagnetic species
[AuCl2(bmiq)]∑ by EPR could be due to its instability even at
-70 ◦C or to very rapid EPR relaxation with concomitant line
broadening of a genuine gold(II) compound. TrueAuII compounds
are still elusive even if several kinds of assumedgold(II) specieswith
extensive spin delocalisation to S and similar donor ligands were
reported.24 In agreement with these results, the DFT calculations
predict considerable structural changes around the metal after
reduction of [AuCl2(bmiq)]+ (Table 2).
The UV-vis spectroelectrochemical reduction of the neutral
precursors to bmiq∑- and [PtCl2(bmiq)]∑- is illustrated in Fig. 9
and 10. The similarity conﬁrms the comparable site of the electron
addition, i.e. the quinoxaline part of bmiq, with its typical
quinoxaline radical absorption of around 600 nm.4,25
Fig. 9 UV-vis spectroelectrochemical monitoring of the reduction of
bmiq in CH3CN/0.1 mol dm-3 Bu4NPF6.
















































Fig. 10 UV-vis spectroelectrochemical reduction of [PtCl2(bmiq)] in
CH3CN/0.1 mol dm-3 Bu4NPF6.
The distinct differences between the isoelectronic platinum(II)
and gold(III) complexes are best explained using DFT calculated
MO energies and diagrams (Table 4, Fig. 11). While the absolute
energies are dependant on the (different) charges, the relative
orbital ordering reveals a signiﬁcant dichotomy: the positively
charged gold system exhibits much more stabilised metal-based
orbitals, leading to a LUMO involving mainly Au–Cl and Au–
N s bonds. The occupation of such MOs generally causes
chemical reactivity such as chloride dissociation.26 In contrast,
the dichloroplatinum analogue has the unoccupied metal-chloride
Table 4 DFT calculated orbital energies of complexes
Orbital energies (DFT)
Orbitals [PtCl2(bmiq)] [AuCl2(bmiq)]+
p* -0.117, -0.088, -0.034 -0.224, -0.202, -0.149
s*(M–Cl) -0.028 -0.263
HOMO -0.198 -0.373
Fig. 11 The DFT-calculated frontier orbital representations of the
one-electron reduced gold and platinum complexes.
s bond orbitals lying above the bmiq ligand-located p* MOs
(Table 4), which results in the observed reversible formation of
a persistent anion radical complex.
Summarising, we could add a new member to the series
(Scheme 1) of quinoxaline-based chelate ligands with separated
metal binding and electron transfer sites. The ligand bmiq provides
imidazole-imine N donors for coordination and could thus model
the binding by two histidine side chains. Moreover, we could
analyse the differences between the isoelectronic [PtCl2] and
[AuCl2]+ complexes experimentally (by cyclic voltammetry, EPR
and UV-vis spectroelectrochemistry) and by DFT. The relative
positioning of the unoccupiedmetal-chloride vs. ligand p* orbitals
determines the presence or absence of reactivity on one-electron
reduction of the [MCl2(bmiq)]n.
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